Overview
Jamie Chaft is an Oncologist in New York, New York. Dr. Chaft is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and EGFR Positive Lung Cancer. Dr. Chaft is currently accepting new patients.
Her clinical research consists of co-authoring 160 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 108 articles and participated in 6 clinical trials in the study of Non-Small Cell Lung Cancer (NSCLC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- PPO
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
530 E 74th St, New York, NY 10021
1275 York Ave, New York, NY 10065
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Memorial Solid Tumor Group
Mark Awad is an Oncologist in New York, New York. Dr. Awad has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Thrombectomy. Dr. Awad is currently accepting new patients.
Memorial Solid Tumor Group
Gregory Riely is an Oncologist in New York, New York. Dr. Riely is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Thymic Epithelial Tumor, Tissue Biopsy, and Liver Embolization. Dr. Riely is currently accepting new patients.
Memorial Solid Tumor Group
Alexander Drilon is an Oncologist in New York, New York. Dr. Drilon is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung AdenocarcinomaDr. Chaft isElite. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Chaft isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Chaft isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Chaft isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Chaft isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Metastatic Pleural TumorDr. Chaft isDistinguished. Learn about Metastatic Pleural Tumor.
- Pleuropulmonary BlastomaDr. Chaft isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Chaft isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- Lung NodulesDr. Chaft isAdvanced. Learn about Lung Nodules.
- Lymphoid HyperplasiaDr. Chaft isAdvanced. Learn about Lymphoid Hyperplasia.
- Metastatic Brain TumorDr. Chaft isAdvanced. Learn about Metastatic Brain Tumor.
- Posterior Fossa TumorDr. Chaft isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)
- Experienced
- Adrenal CancerDr. Chaft isExperienced. Learn about Adrenal Cancer.
- Anal CancerDr. Chaft isExperienced. Learn about Anal Cancer.
- EmphysemaDr. Chaft isExperienced. Learn about Emphysema.
- Hereditary NeuroblastomaDr. Chaft isExperienced. Learn about Hereditary Neuroblastoma.
- Lymphofollicular HyperplasiaDr. Chaft isExperienced. Learn about Lymphofollicular Hyperplasia.
- Marginal Zone Lymphoma (MZL)Dr. Chaft isExperienced. Learn about Marginal Zone Lymphoma (MZL).